Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Azaz Ahmed

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Journal of Clinical Investigation|April 5, 2016
mTORC2 critically regulates renal potassium handlingFlorian Grahammer, Viatcheslav Nesterov, Azaz Ahmed, et al.
Langenbeck'S Archives of Surgery|May 22, 2025
Pancreatic resection with perioperative drug repurposing of propranolol and etodolac - the phase II randomized controlled PROSPER trialFelix J Hüttner, Rosa Klotz, Nathalia A Giese, et al.
Journal of Cancer Research and Clinical Oncology|May 17, 2022
Top 10 research priorities in colorectal cancer: results from the Colorectal Cancer Priority-Setting PartnershipRosa Klotz, Magdalena Holze, Colette Dörr-Harim, et al.
Clinical and Translational Science|November 3, 2023
Protocol of the IntenSify-Trial: An open-label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab-paclitaxel in patients with advanced stage or metastatic pancreatic ductal adenocarcinoma to evaluate the combination's pharmacokinetics, safety, and efficacyNicolas Hohmann, Martin Ronald Sprick, Moritz Pohl, et al.
Anesthesia and Analgesia|February 9, 2024
Thoracic Epidural Analgesia Is Not Associated With Improved Survival After Pancreatic Surgery: Long-Term Follow-Up of the Randomized Controlled PAKMAN TrialRosa Klotz, Azaz Ahmed, Anja Tremmel, et al.
Oncoimmunology|August 21, 2019
CCR5 status and metastatic progression in colorectal cancerMeggy Suarez-Carmona, Pornpimol Chaorentong, Jakob Nikolas Kather, et al.
JCI Insight|August 14, 2025
Photon and particle radiotherapy induce redundant modular chemotaxis of human lymphocytesJoscha A Kraske, Michael M Allers, Aleksei Smirnov, et al.
Science Advances|March 23, 2022
Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8Thomas Walle, Joscha A Kraske, Boyu Liao, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Journal of Clinical Investigation|April 5, 2016
mTORC2 critically regulates renal potassium handlingFlorian Grahammer, Viatcheslav Nesterov, Azaz Ahmed, et al.
Langenbeck'S Archives of Surgery|May 22, 2025
Pancreatic resection with perioperative drug repurposing of propranolol and etodolac - the phase II randomized controlled PROSPER trialFelix J Hüttner, Rosa Klotz, Nathalia A Giese, et al.
Journal of Cancer Research and Clinical Oncology|May 17, 2022
Top 10 research priorities in colorectal cancer: results from the Colorectal Cancer Priority-Setting PartnershipRosa Klotz, Magdalena Holze, Colette Dörr-Harim, et al.
Clinical and Translational Science|November 3, 2023
Protocol of the IntenSify-Trial: An open-label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab-paclitaxel in patients with advanced stage or metastatic pancreatic ductal adenocarcinoma to evaluate the combination's pharmacokinetics, safety, and efficacyNicolas Hohmann, Martin Ronald Sprick, Moritz Pohl, et al.
Anesthesia and Analgesia|February 9, 2024
Thoracic Epidural Analgesia Is Not Associated With Improved Survival After Pancreatic Surgery: Long-Term Follow-Up of the Randomized Controlled PAKMAN TrialRosa Klotz, Azaz Ahmed, Anja Tremmel, et al.
Oncoimmunology|August 21, 2019
CCR5 status and metastatic progression in colorectal cancerMeggy Suarez-Carmona, Pornpimol Chaorentong, Jakob Nikolas Kather, et al.
JCI Insight|August 14, 2025
Photon and particle radiotherapy induce redundant modular chemotaxis of human lymphocytesJoscha A Kraske, Michael M Allers, Aleksei Smirnov, et al.
Science Advances|March 23, 2022
Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8Thomas Walle, Joscha A Kraske, Boyu Liao, et al.
Pageof 2